| International position paper on febuxostat. | |
| | |
MedLine Citation:
|
PMID: 20401506 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This position paper aims to clarify the presumed place of febuxostat in the management of gout patients. Since this novel xanthine oxidase inhibitor is now available, an international group of gout experts decided to formulate an international consensus statement. This statement presents the place for this new xanthine oxidase inhibitor in the treatment of gout which may contribute to optimize treatment of gout patients in Europe and worldwide. |
| | |
Authors:
|
Tim L Jansen; Pascal Richette; Fernando Perez-Ruiz; Anne-Kathrin Tausche; Philip-André Guerne; Leonardo Punzi; Burkhard Leeb; Victoria Barskova; Till Uhlig; José Pimentão; Irena Zimmermann-Górska; Elisio Pascual; Thomas Bardin; Michael Doherty |
Related Documents
:
|
4751386 - Calcium efflux from internally dialyzed squid giant axons. 20695166 - Spain and the international scientific conferences on polio, 1940s-1960s. 21932946 - Trends in sheltering and welfare at the hawaiian humane society, oahu, hawaii. 20663696 - International society for clinical densitometry official positions: asia-pacific region... 20591036 - Role of distal protection devices. 22493186 - Ethical issues raised by the introduction of payment for performance in france. |
Publication Detail:
|
Type: Consensus Development Conference; Journal Article; Review Date: 2010-04-17 |
Journal Detail:
|
Title: Clinical rheumatology Volume: 29 ISSN: 1434-9949 ISO Abbreviation: Clin. Rheumatol. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-02 Completed Date: 2010-10-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8211469 Medline TA: Clin Rheumatol Country: Germany |
Other Details:
|
Languages: eng Pagination: 835-40 Citation Subset: IM |
Affiliation:
|
Department of Rheumatology, Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands. t.jansen@znb.nl |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Gout
/
drug therapy* Gout Suppressants / therapeutic use* Humans International Cooperation Thiazoles / therapeutic use* Treatment Outcome Xanthine Oxidase / antagonists & inhibitors |
| Chemical | |
Reg. No./Substance:
|
0/Gout Suppressants; 0/Thiazoles; 144060-53-7/febuxostat; EC 1.17.3.2/Xanthine Oxidase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: [Treatment quality in geriatric patients with diabetes mellitus in various home environments].
Next Document: Vancomycin-heteroresistant phenotype in invasive methicillin-resistant Staphylococcus aureus isolate...